ARTICLE | Clinical News
Coulter begins Phase II
April 26, 2000 7:00 AM UTC
CLTR and partner SmithKline Beecham (LSE:SB; SBH) began a 30-patient Phase II trial of CLTR's Bexxar iodine I 131 tositumomab in combination with CVP (cyclophosphamide, vincristine and prednisone) to ...